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ABSTRACT
Purpose: Reliable dose estimation is an important factor in appropriate dosimetric triage categorization
of exposed individuals to support radiation emergency response.
Materials and methods: Following work done under the EU FP7 MULTIBIODOSE and RENEB projects,
formal methods for defining uncertainties on biological dose estimates are compared using simulated
and real data from recent exercises.
Results: The results demonstrate that a Bayesian method of uncertainty assessment is the most appro-
priate, even in the absence of detailed prior information. The relative accuracy and relevance of techni-
ques for calculating uncertainty and combining assay results to produce single dose and uncertainty
estimates is further discussed.
Conclusions: Finally, it is demonstrated that whatever uncertainty estimation method is employed,
ignoring the uncertainty on fast dose assessments can have an important impact on rapid biodosimet-
ric categorization.
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Introduction
Biological markers of radiation exposure are important tools
for determining radiation doses for exposed or suspected
exposed individuals following a mass-casualty radiation acci-
dent or incident (Swartz et al. 2014). Members of the
European Union (EU) 7th Framework Programme (FP7)
Realizing the European Network of Biodosimetry (RENEB)
retrospective dosimetry mutual assistance network and
European Radiation Dosimetry Group (EURADOS) Working
Group (WG) 10 on retrospective dosimetry have been devel-
oping and validating existing and new physical and bio-
logical exposure markers, to ensure that network members
are ready to provide retrospective dosimetry to support
emergency responders in the event of a large scale radio-
logical event. Rapid biodosimetric categorization of individu-
als suspected of being exposed to ionizing radiation is based
on dose information from the individual RENEB assays – the
biological techniques based on scoring of dicentrics (DIC),
micronuclei (MN), gamma-H2AX foci, prematurely condensed
chromosomes (PCC), and the physical techniques of electron
paramagnetic resonance (EPR) and optically stimulated lumi-
nescence (OSL) (Kulka et al. 2015, 2016).
In the initial phase of a response to a mass casualty
exposure scenario, triage of individuals for medical purposes
is generally based solely on where individuals were and for
how long together with the presence/absence of prodromal
signs. However, the stress and uncertainty following such an
event and the inherent inter-individual variability mean that
these criteria are known to be unreliable. Thus the need for
more quantitative secondary triage methods, which can be
provided by the biodosimetry community, is well docu-
mented (Sullivan et al. 2013). Although the main focus of
large scale accident biodosimetry is rapid dose estimation to
assist emergency responders in identifying those in greatest
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need of medical intervention, it is important to keep in mind
that all biological and physical methods of retrospective dos-
imetry result in dose estimates with non-zero uncertainties,
and the incertitude associated with biological dose estimates
can be considerable. Methods of uncertainty estimation for
screening doses and biodosimetry triage or rapid categoriza-
tion were previously developed under the EU FP7 multi-
disciplinary biodosimetric tools to manage high scale
radiological casualties (MULTIBIODOSE) project (Jaworska
et al. 2015). Under RENEB, work has continued to refine the
biological and statistical aspects of the assays to ensure
readiness of the community to respond to a radiological or
nuclear accident or incident (Barnard et al. 2015; Kulka et al.
2015; Abend et al. 2016).
In this paper, the results of some recent work to refine
the statistical aspects of the dosimetry methods are
described, focusing on formal assessment of the uncertainties
associated with rapid dose estimates and the associated cat-
egorization of individuals to support medical triage.
Simulations based on recent data have been used to test
and compare uncertainty estimation methods relying on the
International Organization for Standardization (ISO) standard
method of propagation of errors (ISO19238, 2014), a simplifi-
cation of this method ignoring covariances between experi-
mental factors used under MULTIBIODOSE (Ainsbury et al.
2014), Merkle’s method for combining the errors on the yield
and curve (Merkle 1983, International Atomic Energy Agency
[IAEA] 2011) the IAEA simplification of this based on the
exact Poisson error (IAEA 2011) and a Bayesian method to
assess radiation dose (Higueras et al. 2015). Where appropri-
ate, the methods have been applied to data from the dicen-
tric, gamma-H2AX, micronucleus and PCC assays. The
probability of correct rapid categorization (< 1 Gy; 1–2Gy;
2þ Gy) given the magnitude of the associated uncertainties
was then tested using data from recent MULTIBIODOSE and
RENEB inter-comparison exercises and the RENEB ‘table-top’
rapid biodosimetric categorization exercise, which amongst
other things has resulted in the creation of a formal expert
consensus for fast assessment (Brzozowska et al. 2016).
Finally, the potential for and implications of inclusion of an
assessment of uncertainty into rapid biodosimetric informa-
tion provided to emergency responders or other medical pro-
fessionals is considered.
Materials and methods
Data and assumptions
For the dicentric assay, the calibration data were taken from
the publication of Barquinero and colleagues (1995) which is
analyzed in detailed examples in the IAEA manual (2011).
The data analyzed for magnitude of uncertainties come from
the DIC data collected during the in vitro exposure simula-
tions carried out under the MULTIBIODOSE and RENEB proj-
ects (Romm et al. 2014; Oestreicher et al. 2016). Uncertainties
were calculated based on both whole body, acute, high dose
rate (HDR) exposures and chronic/low dose rate (LDR) curves
and data. The MN calibration curve data and test data were
taken from Thierens et al. (2014), representing data collected
under the MULTIBIODOSE project. Uncertainties were again
calculated based on both HDR and LDR curves and data. For
LDR exposures for the dic and MN assays, a total exposure
time of 10 h and a repair time, t0, of 2 h was assumed.
The gamma-H2AX curve data were taken from the 4- and
24-h calibration curves established at Public Health England
(PHE) as part of the MULTIBIODOSE project (Rothkamm et al.
2013) and the test data were taken from the recent RENEB
inter-comparison (Barnard et al. 2015). For the gamma-H2AX
assay, it is recommended to apply at least one positive con-
trol to produce a reference sample ratio value, representing
the ratio of the measured response at the chosen dose to
the calibration curve response at the corresponding dose
value. For this work, a relative reference sample ratio (r) value
of 1 and reference sample standard deviation (SD) of sqrt(1)
(a Poisson assumption) was assumed. The PCC curve and test
data were taken from recent work done under RENEB
(Terzoudi et al. 2016) for simulated high dose rate acute
exposures.
Test data for all assays and scenarios were also taken from
the RENEB accident simulation (Brzozowska et al. 2016), in
order to test the impact of including uncertainty estimation
on rapid biodosimetry categorization. Uncertainty calculations
were based on the number of aberrations observed in 50
cells for all assays, corresponding to the recommended meth-
ods for fast dose assessment purposes.
Uncertainty analysis methods
The uncertainty associated with each assay/scenario was cal-
culated as follows:
1. ISO propagation of errors (‘ISO method’). In the usual
scenario, i.e. that yield of dicentrics/micronuclei and
dose follow a linear-quadratic relationship, dose is calcu-
lated using Equation (1):
D ¼ a6
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
a2 þ 4bðy  AÞp
2b
(1)
where D is dose, A is the (fitted) background rate, a is
the linear coefficient, b is the quadratic coefficient, and y
is the measured yield of dicentrics per cell. As discussed
in the ISO standard (2014), the procedure for estimating
the uncertainty on the dose is based on the general
case:
r2D ¼
@D
@a
 2
r2a þ
@D
@b
 2
r2b þ
@D
@A
 2
r2A þ
@D
@y
 2
r2y
þ 2 @D
@a
 
@D
@b
 
cov a; bð Þ þ 2 @D
@a
 
@D
@A
 
cov a;Að Þ
þ 2 @D
@A
 
@D
@b
 
covðA; bÞ
(2)
For the LDR exposure scenario, the relationship between
the yield and dose is also reliant on the total exposure
(t) and repair time (t0), and thus b in Equation (1) is
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replaced with the Lea and Catcheside function b’ (IAEA
2011):
b
0 ¼ b 2t=t0
t
t0
 1þ e tt0
 
(3)
This leads to the addition of corresponding components
based on t and t0 in Equation (2).
For the gamma-H2AX assay, the situation is simplified in
that the dose response is linear, but according to RENEB
and MULTIBIODOSE procedures, at least one positive
control or reference sample (r) must be included in each
analysis to ensure that the applied calibration curve is
suitable for the data being analyzed. As such, Equation
(1) is modified to give:
D ¼ y  A
a
r (4)
The corresponding Equation (2) for the H2AX assay
thus contains partial derivative components for y, A, a,
and r and all the corresponding covariance (cov) com-
ponents.
For the PCC assay, the relationship between dose and
excess PCC fragments is linear and thus Equation (4)
can be applied in the absence of the reference sample
(r) component and the corresponding uncertainty cal-
culation only requires partial derivatives for y, A, a and
the corresponding covariance components.
2. MULTIBIODOSE simplification (‘MBD method’). Given that
the uncertainties associated with fast biodosimetry are
large and that the relative magnitude of the covari-
ance components is very small, under MULTIBIODOSE
it was suggested that the equations above could be
simplified for uncertainty calculation for fast assess-
ment purposes by ignoring the covariance components
entirely:
r2D ¼
@D
@a
 2
r2a þ
@D
@b
 2
r2b þ
@D
@A
 2
r2A þ
@D
@y
 2
r2y (5)
3. Merkle’s method for consideration of Poisson error on
yield and error in calibration curve coefficients (‘Merkle
method’). The IAEA manual (2011), which is used by
many members of the retrospective dosimetry commu-
nity, presents Merkle’s proposals (1983) as the simplest
method for calculation of uncertainties on dose esti-
mates. The method is described in detail in the man-
ual (IAEA 2011), however, in brief, it relies on
calculation of the upper and lower 95% confidence
limits on the yield (yyu and yyl) according to the
Poisson distribution, using Equations (6) and (7)
respectively:
yyu ¼ 0:5vq 0:025; 2ynþ 2ð Þn (6)
yyl ¼ 0:5vq 0:975; 2ynð Þn (7)
where vq is the quantile function of the Chi-squared
distribution for percentage point, degrees of freedom of
2yn þ2 for yyu or 2yn for yyl.
Calculation of the upper and lower confidence limits on
the curve (ycu(D) and ycl(D)) is then carried out according
to Equation (8):
ycu=clðDÞ
¼ Aþ aDþ bD26R
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2A þ s2aD2 þ s2bD4
þ2sA;aDþ 2sA;bD2 þ 2sa;bD3
s
(8)
where s2x is the variance of x and sx;z the covariance of x
and z. The regression confidence factor R2 is the 95%
confidence limit of the Chi-squared distribution with 2
or 3 degrees of freedom for linear or linear-quadratic
fits, respectively; i.e. for 95% confidence limits, R¼ 2.45
or R¼ 2.80, respectively. Finally, determine the dose at
which the yield yyl intersects with ycu(D) to give the
lower confidence limit on the dose, and determine the
dose at which yyu intersects with ycl(D) to give the upper
confidence limit on the dose.
4. IAEA simplification (‘IAEA’). In addition to the above, sev-
eral methods for calculating the confidence limits on
estimated doses, usually characterised as the 95% confi-
dence limits, are recommended and discussed in the
IAEA manual for biodosimetry (2011). As the dominant
contribution to uncertainty in rapid categorization mode
is likely to be the Poisson error on the number of scored
aberrations, the simplified method of calculating uncer-
tainty based on the exact Poisson 95% confidence limits
has been implemented here for comparison with the
alternative methods. The upper (yyu) and lower (yyl)
Poisson confidence limits on the yield are calculated as
above. The limits yyu and yyl are then converted to confi-
dence limits on dose by substituting these values into
Equation (1).
5. Bayesian calibrative density calculations (Bayes). A
Bayesian approach to biodosimetry data analysis and
dose estimation has been gaining popularity in recent
years, with several new methods appearing in the recent
literature, including the approach of Higueras and col-
leagues (2015) who developed a new inverse regression
model applied to radiation biodosimetry using Poisson
or compound Poisson responses, which produces a pos-
terior dose distribution or calibrative density. An R pro-
gramming language (R Core Team 2014) library has
recently been created to reproduce the methodology
(Mori~na et al. 2015).
Calculations and simulations
The R programming language (R Core Team 2014) core func-
tions and radir library (Mori~na et al. 2015) were used to cal-
culate calibration curve coefficients and covariance matrices
and dose and uncertainty estimations based on the above
three methods.
Next, based on the calibration data of Barquinero et al.
(1995), dicentric samples were simulated for several fictitious
scenarios, simulating numbers of dicentric aberrations caused
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by irradiations of 0.5 Gy in 50 and 2002 lymphocytes, 1.5 Gy
in 50 and 562 cells, and 3Gy in 50 and 193 cells. These doses
and their dicentric distributions are taken from the calibra-
tion data, so at each simulated scenario the absorbed dose
sample, the test data, is not included in the calibration data
set, thus simulating the level of uncertainty implicit in bio-
logical dose estimations. The simulations were generated by
non-parametric bootstrap methodology, simulating samples
with replacement from the original one. At each iteration,
the calibration and test data are simulated, then the fitted
dose-response coefficients, the variance-covariance matrix
and the sample sum of the test data are collected. Finally,
the dose estimation uncertainty was calculated using the five
different methods analyzed in this manuscript, and it was
checked to see whether the confidence (credible) interval
contained the absorbed dose. The simulations were per-
formed for 95% confidence (credible) regions, so the value
closest to 95% indicates the most accurate estimation
method.
Following calculation of the uncertainties using the data
as described above for each of the ISO, MULTIBIODOSE,
Merkle and IAEA and Bayesian methodologies, probabilities
of correct rapid categorization as either <1Gy; 1–2Gy or 2þ
Gy were then calculated using the cumulative standard nor-
mal distribution for doses in increments of 0.05Gy from
0–3Gy (results not reported), for each assay/exposure scen-
ario, or using radir to implement the Bayesian methodology
of Higueras et al. (2015). For the calibrative density calcula-
tions, the absorbed dose prior distribution was assumed to
be uniform; the calibration curve information was collected
in a univariate prior assumed to be gamma distributed.
The dosimetry data were then taken from the recent
RENEB table top exercise to estimate the impact of the find-
ings on fast dose assessment in a real accident. The mean
uncertainty reported in rapid categorization mode in the
publications listed above was calculated for the relevant
exposure scenarios at doses of 0, 0.5, 1, 1.5,2 and 2.5 Gy and
applied to the DIC, MN, gamma-H2AX and PCC assay data
(doses only) from the RENEB table top exercise (Brzozowska
et al. 2016). The standard normal distribution was then used
to calculate the probability of correct categorization for each
data point (consisting of the mean of the dosimetry results
from each of the assays) from the RENEB exercise, in order to
test the impact of uncertainty on the success of the rapid
dose assessment and categorization procedure. For instance,
a nominal dose of just above 1Gy might, in fact, have a
larger probability given the applied uncertainty of being in
the <1Gy category than the ‘correct’ 1–2Gy category.
Results
The fitted calibration coefficients used for the four assays are
given in Table 1.
Table 2 describes the results of the simulations of cover-
age of the various uncertainty characterisation methods
applied to the dicentric assay.
Figure 1 illustrates the relative magnitude of the uncer-
tainties calculated for the MULTIBIODOSE methodology, for
doses of 0, 0.5, 1, 1.5, 2 and 2.5 Gy. Table 3 gives the
Table 1. Calibration curve coefficients and covariances, calculated using R (2014), for the four biodosimetry assays.
Coefficients
Assay Data Scenario A a b cov a b cov a A cov A b
Dicentric Barquinero et al. (1995) HDR/LDR 0.0013 ± 0.0005 0.0216 ± 0.0052 0.0621 ± 0.0039 1.49E-05 9.83E-07 4.25E-07
Micronucleus Thierens et al. (2014) HDR/LDR 0.0316 ± 0.0045 0.0631 ± 0.0083 0.0110 ± 0.0022 1.73E-05 2.58E-05 5.42E-06
Gamma-H2AX Rothkamm et al. (2013) HDR 4 hr 0.6454 ± 0.0822 2.4686 ± 0.0676 – – 2.90E-03 –
HDR 24 hr 0.1060 ± 0.0379 0.8227 ± 0.0455 – – 7.57E-04 –
PCC Terzoudi et al. (2016) HDR 3.465E-10 ± 4.094E-6 1.1978 ± 0.0295 – – 3.66E-12 –
This value was taken as 0 for further analyses.
Table 2. Non-parametric bootstrap simulation of dicentric assay results to
assess the magnitude of the confidence limits actually covered for a desired
confidence level of 95%. The most accurate confidence (credible) region values
for each experiment, those closer to 95%, are given in bold.
Dose, Gy Method Cells Coverage, % Cells Coverage, %
0.5 ISO 2002 94.47 50 80.68
MBD 96.94 80.52
IAEA 92.05 98.86
Merkle 99.88 99.52
Bayes 94.68 97.14
1.5 ISO 562 94.03 50 93.81
MBD 96.81 94.23
IAEA 92.51 95.86
Merkle 99.40 98.14
Bayes 93.53 93.90
3.0 ISO 193 67.71 50 87.77
MBD 74.22 88.65
IAEA 63.96 90.56
Merkle 96.53 97.98
Bayes 71.84 90.10
830 samples were excluded, due to resulting negative values for the square
root term applying Equation (1).
Figure 1. Comparison of standard deviations based on simulated chromosome
aberration data for doses of 0, 0.5, 1, 1.5, 2 and 2.5 Gy using the MBD method
for the four assays: bold dotted line – DIC; solid line – MN; bold dashed line –
gamma-H2AX; bold solid line – PCC.
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probability based on the cumulative normal distribution or
the Bayesian probability that, given the magnitude of the
uncertainties calculated using each method, the categories
were correct. Figure 2 illustrates one example from Table 3 –
the posterior dose distribution (calibrative density) for a
simulated HDR exposure resulting in a yield of 0.17 dicentrics
per cell to give a nominal dose of 1.5 Gy. The expected dose
is 1.53 ± 0.28. The probability of being in between 1 and 2Gy
(shaded in grey) is calculated as 0.917.
The average magnitude of the uncertainties was then
applied to the RENEB table top exercise data before the
cumulative normal distribution was used to calculate the
probability that the dose fell in each of the three rapid
assessment categories: <1Gy, 1–2Gy or 2þ Gy. The cat-
egory that had the highest probability was assigned in each
case. The results were then compared to the category
assignments based on dose alone. Overall, less than 2% of
the responses based on the probabilities were assigned to
categories lower than expected, and these were those
responses corresponding to doses just above 1Gy. For
instance, a dose of 1.05 Gy has a standard deviation of
approximately 0.68 Gy (mean SD from the four assays com-
bined). This means that there is a cumulative probability of
0.471 that the actual exposure was less than 1Gy and a
probability of 0.447 that the exposure fell between 1 and
2Gy. Thus, incorporating the uncertainty means that this
nominal dose of 1.05 Gy has a slightly higher probability of
being incorrectly assigned to the <1Gy category compared
to the correct 1–2Gy category. Applying the same proced-
ure, 11% of the RENEB samples were categorized as being
too high: these are doses above approximately 1.65 Gy (and
below 2Gy) for which the width of the normal distribution
around the dose meant that they had a higher probability
of being in the 1–2Gy category.
Figure 3 illustrates in full the variation in probability that a
dose is placed in the correct category <1Gy, 1–2Gy or 2þ
Gy with dose.
Discussion
Retrospective dosimetry to assist in triage of exposed or sus-
pected exposed individuals following a large scale radiation
accident or incident implies provision of dose estimates
which are as accurate as possible within the shortest time
possible. Biodosimetry is a recognized method to support tri-
age and the large amount of work completed under the
RENEB project has ensured that EU laboratories maintain
Table 3. Cumulative normal (ISO, IAEA, Merkle and MBD) or Bayesian posterior probabilities of being in correct triage category, given calculated
uncertainties, for simulated doses of 0, 0.5, 1, 1.5, 2 and 2.5 Gy.
Actual dose
Assay Exposure details Method 0 Gy 0.5 Gy 1 Gy 1.5 Gy 2 Gy 2.5 Gy
Dicentric HDR ISO 1.000 0.962 0.500 0.921 0.500 0.958
IAEA 1.000 0.990 0.500 0.949 0.500 0.969
Merkle 1.000 0.980 0.500 0.898 0.499 0.924
MBD 1.000 0.962 0.500 0.917 0.500 0.955
Bayes 0.996 0.962 0.513 0.917 0.444 0.965
LDR ISO 1.000 0.987 0.500 0.971 0.500 0.983
MBD 1.000 0.986 0.500 0.970 0.500 0.982
Bayes 0.934 0.739 0.470 0.697 0.488 0.867
Micronucleus HDR ISO 0.993 0.845 0.500 0.616 0.453 0.794
IAEA 0.999 0.884 0.500 0.670 0.468 0.814
Merkle 1.000 0.876 0.500 0.608 0.447 0.776
MBD 0.993 0.843 0.500 0.603 0.447 0.781
Bayes 0.966 0.791 0.483 0.608 0.448 0.830
LDR ISO 0.993 0.861 0.500 0.685 0.476 0.836
MBD 0.993 0.862 0.500 0.679 0.473 0.827
Bayes 0.903 0.713 0.385 0.508 0.349 0.822
gamma-H2AX 4 h ISO 1.000 0.998 0.500 0.712 0.447 0.742
MBD 1.000 0.998 0.500 0.714 0.447 0.742
Bayes 1.000 1.000 0.469 1.000 0.484 1.000
24 h ISO 1.000 0.993 0.500 0.678 0.462 0.732
MBD 1.000 0.993 0.500 0.682 0.436 0.733
Bayes 1.000 0.999 0.481 0.975 0.447 0.978
PCC HDR ISO 1.000 1.000 0.500 0.998 0.500 0.990
MBD 1.000 1.000 0.500 0.998 0.500 0.990
Bayes 1.000 1.000 0.458 0.996 0.466 0.996
Figure 2. Example normalized posterior dose distribution (‘calibrative density’)
for a simulated HDR exposure resulting in a yield of 0.17 dicentrics per cell to
give a nominal dose of 1.5 Gy. The expected dose is 1.53 ± 0.28. The probability
of being in between 1 and 2 Gy (shaded in grey) is calculated as 0.917.
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emergency response readiness (Kulka et al. 2016). The RENEB
‘toolkit’ contains a number of assays, including the four
assessed in this paper – further details of which can be found
in Oestreicher et al. (2016) for the dicentric assay; Depuydt
et al. (2016) for the micronucleus assay; Moquet et al. (2016)
for the gamma-H2AX assay and Terzoudi et al. (2016) for the
PCC assay. The results of the most recent RENEB table-top
exercise demonstrated a very good agreement between labo-
ratories, with a mean categorization accuracy (defined as the
number of triage categorization answers which were the
same as the default values, divided by the number of all
answers) of 95% throughout the entire exercise (Brzozowska
et al. 2016).
A large amount of work has shown that analysis of the
number of dicentrics in 50 cells is sufficient for this purpose
(e.g. Romm et al. 2013) and thus, for the comparisons within
study, 50 cells was chosen for all assays. However, it should
be noted that recommendations differ between the assays.
For the micronucleus assay, a larger number of approxi-
mately 200 cells is required (Thierens et al. 2014); for
gamma-H2AX and PCC, 20–30 cells may be sufficient
(Barnard et al. 2015; Karachristou et al. 2015). However, while
uncertainties have been analyzed in order to provide an indi-
cation of the number of cells that might result in a suitably
reliable dose estimate, the impact of uncertainty on the rapid
biodosimetry categorization results has not been considered.
In this work, a number of different methods of calculation
of uncertainty for biodosimetry dose estimates have been
assessed and compared: a method based on the ISO stand-
ard methodology; the MULTIBIODOSE simplification of this
method ignoring the covariance terms; a method to incorp-
orate Poisson uncertainty on the yield of aberrations with
the error on the calibration curve; one other of the sug-
gested methods from the IAEA manual (which, in practice, is
what many laboratories are currently using), and a method
based on Bayesian assessment of the prior dose and calibra-
tion data to produce a posterior ‘calibrative density’ dose dis-
tribution which fully incorporates all the uncertainty
contributions. In practical terms, the differences in
magnitudes of calculated uncertainties between the methods
are generally small. Indeed, the simulation results in Table 2
demonstrate that the most accurate methodology, assessed
by the magnitude of the confidence limits, depends on the
dose and the number of cells. The Bayesian methodology of
Higueras and colleagues (2015) is the most accurate at a rela-
tively low dose of 0.5 Gy for dose assessments in both the
routine (200–2000 cell) and rapid (50 cell) dosimetry scen-
arios. For the highest dose of 3 Gy, the Merkle method gave
the most accurate coverage, and for the intermediate chosen
dose of 1.5 Gy, the ISO/MBD methods were the most success-
ful. The MULTIBIODOSE simplification provides more conser-
vative dose estimation uncertainties than the ISO method,
due to the fact that the largest covariance of the calibration
curve fitting is negative (Table 1). The IAEA simplification is
not always conservative, in contrast to the more detailed
Merkle methodology which includes both scoring uncertainty
and error on the curve coefficients (IAEA 2011; Higueras et al.
2015), and thus which results in the largest uncertainties.
Further, Table 3 and Figure 3 demonstrate that when the
uncertainty on dose is accounted for by assigning categories
based on probability, albeit in a very simplified manner, it is
possible that an incorrect categorization may result. For
instance, Figure 3 demonstrates that at 1 Gy, as might be
expected, there is a probability of approximately 50% that
the estimated dose would be placed in the <1Gy category
and approximately 45% that the dose would be placed in
the 1–2Gy category. This highlights the qualitative nature of
such categorization. For the ISO, MBD, IAEA and Merkle
methodologies, the method of accounting for uncertainty in
this publication, by relying on the standard normal distribu-
tion, is rather simplistic as the aim is to demonstrate that
uncertainty may have a more important role than has previ-
ously been considered for emergency biodosimetry. In add-
ition, the R2 regression confidence factor (corresponding to
the confidence limit of the Chi-square distribution) was
chosen as 7.81 for 95% coverage (IAEA 2011). However, some
authors have suggested that for the Merkle method, this
results in overestimation of the uncertainty, and thus a lower
coverage factor should be applied (IAEA 2011). This requires
further investigation.
General considerations for uncertainty for biodosimetry
have recently been addressed by several authors (e.g.
Szłuinska et al. 2007; Vinnikov et al. 2010). Several publica-
tions have demonstrated that distributions other than the
Poisson may be more applicable to yields of chromosome
aberrations (e.g. Ainsbury et al. 2013; Higueras et al. 2015,
Oliveira et al. 2016), for example, and thus it is possible that
radiation dose estimates may be more accurately described
by alternative distributions to the Poisson. The Bayesian
approach allows much more accurate characterization of the
dose distribution as it is based on the combined information
regarding the potential dose and exposure scenario, the cali-
bration coefficients and the yield of aberrations. It should be
noted that in some circumstances, the Bayes method applied
here, as illustrated in Table 3, gives the lowest probability of
the ‘correct’ categorization. This stems from the fact that the
Bayesian approach intrinsically incorporates the prior infor-
mation provided and, in this case the least informative
Figure 3. Cumulative probability of correct categorization – probability that a
dose is placed in the category 0–1 Gy (solid line), 1–2 Gy (dashed line) or 2þ Gy
(dotted line).
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approach to Bayesian calculations was also taken here: using
an improper uniform dose prior which would be applied in a
real life situation if there was no prior dose information avail-
able (as does sometimes occur). A more sophisticated ana-
lysis based on more appropriate priors for the specific
exposure scenario should yield much improved results in real
life analyses.
An additional limitation of this study is that only a small
amount of data has been tested, and in most cases simplified
assumptions have been applied – for instance the use of 50
cells, an exposure time of 10 h and a t0 of 2 h throughout.
For the gamma-H2AX assay in particular, although the idea
to include a reference sample as a positive control has been
incorporated into the uncertainty calculations, several add-
itional experimental variables have been ignored. For
instance, in a real life accident exposure scenario, it is highly
unlikely that samples would be taken after exactly 4 or 24 h,
thus a correction for time should also be included. Indeed, in
practice, the uncertainty imparted as a result of all the add-
itional experimental factors needs further consideration in
order that these can be fully incorporated into the uncer-
tainty budget.
Further, while the ISO recommendations for uncertainty
characterization, based on propagation of errors, can readily
be applied to the full range of assays and exposure scenarios
explored in this manuscript, the IAEA manual methods are
geared towards dicentric analysis following only one specific
scenario of acute, high dose rate, low linear energy transfer
exposures up to approximately 5 Gy (i.e. those resulting in
well-defined linear quadratic dose response relationships up
to the ‘saturation dose’; IAEA 2011). While these methods
were judged to be applicable for the micronucleus assay,
and have thus been applied here for both assays in the HDR
scenario, it was not judged to be suitable for the other scen-
arios and assays included in this manuscript. Further work
would be required to develop similar simplified methodolo-
gies for the gamma-H2AX and PCC assays and for chronic
exposures. Also for partial body exposures, which have not
been considered in this article.
The calibration curves, assays and exposure scenarios ana-
lyzed in this work were chosen in an attempt to sample a
wide range of potential situations in which dosimetry might
be required. This includes taking a manually scored dicentric
curve (i.e. one created by eye rather than by automated
dicentric detection) and applying it in acute and chronic
exposure scenarios; an automated micronucleus assay curve
applied similarly; applying the gamma-H2AX assay for dose
assessment at 4 and 24 h, and comparing all these with the
PCC assay methodology used in RENEB (Terzoudi et al. 2016).
Nevertheless, further work will be required to fully assess the
impact of all experimental variables in the full range of
potential exposure scenarios on the magnitude of the uncer-
tainty. The uncertainties for the additional RENEB/EURADOS
operational assays – EPR and OSL – should also be consid-
ered in detail, as should those for the newer methods such
as thermoluminescence spectroscopy and gene expression
which are now being tested and validated (Ainsbury et al.
2016). The obvious place for this work and the associated
biological and physical development would be as part of
RENEB/EURADOS joint exercises going forward.
Overall, in terms of impact on rapid biodosimetry categor-
ization, the results from the RENEB accident simulation exer-
cise show that inclusion of uncertainty has a relatively low
impact. However, for doses between 1.7 and 2Gy (within
the assumptions of this study), it is possible that individuals
may be incorrectly categorized as being of 2 Gy or higher and,
more importantly from a medical point of view, for exposures
just above 1Gy there is a clear risk of miscategorization as a
0–1Gy event. While the above results show that the probabil-
ity of misclassification increases towards the categorization
boundaries (i.e. close to 1 or 2Gy), a sensible approach in any
case might be to check the positions of the 95% confidence
limits which will give an indication of the likelihood that the
dose and category have been correctly assigned.
It is undoubtedly hugely important for practising mem-
bers of the international biodosimetry community to have a
good grasp of the uncertainties associated with dose esti-
mates in both routine and emergency response scenarios.
This comparison of methods has thus been useful in provid-
ing a benchmark for the likely levels of uncertainty that will
be observed, albeit with the limitations listed above.
However, an important point for consideration is whether it
will be possible to include the uncertainty estimates in the
rapid biodosimetry categorization procedure and, further,
whether the medical professionals to whom the dose infor-
mation will be provided will be interested in the accuracy of
the results. The first part of this question was considered in
part during the MULTIBIODOSE final biodosimetry triage cat-
egorization exercise. The results showed that, considering
dose alone, approximately 70% of samples were correctly
categorized. However, it was found that incorporating uncer-
tainty estimates into the analysis did not improve dose cat-
egorization results, rather the opposite (Ainsbury et al. 2014).
For the second part of the question, the current consensus
within the field is that in a radiation emergency, the acute
phase responders will not have time to deal with uncertainty
estimates in addition to dose estimates; rather it will be suffi-
cient to say that the retrospective dosimetry estimates pro-
vided are highly uncertain, but are the best that can be done
given the constraints of acting in fast assessment mode.
However, to the knowledge of the authors, this has not yet
been discussed in detail with the relevant stakeholders, and
thus further work to clarify the related issues will be essential
before further development can take place.
Conclusions
Four methods of uncertainty estimation for radiation bio-
dosimetry have been tested and compared. As expected, the
Bayesian approach detailed in this publication intrinsically
provides the most complete assessment of dose in the form
of a posterior probability distribution. However, the
approaches recommended by the ISO standard, the IAEA
manual (including the Merkle methodology) and the simpli-
fied MBD version were comparable in their performance and
thus all methods have been shown to characterize
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uncertainty reasonably well for the purposes of retrospective
dosimetry to support emergency response.
The results of this work highlight the importance of accur-
ate characterization of dose uncertainties, which can directly
impact rapid biodosimetry categorization of suspected
exposed individuals. However, the practical implications of
incorporating assessment of uncertainty into fast assessment
results provided to medical professionals need to be further
considered.
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